HomeCERS • NASDAQ
Cerus Corp
$1.40
1.09%
+0.015 Today
Apr 2, 3:35:03 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
020M40M
Revenue
Net Income
Revenue
Net income
(USD)Dec 2024Y/Y change
Revenue
50.81M8.64%
Operating expense
28.83M15.41%
Net income
-2.52M-89.83%
Net profit margin
-4.96-74.65%
Earnings per share
-0.010.00%
EBITDA
-1.12M-168.82%
Effective tax rate
-4.53%
050M100M150M200M
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD)Dec 2024Y/Y change
Cash and short-term investments
80.45M22.17%
Total assets
200.92M1.60%
Total liabilities
144.02M-0.20%
Total equity
56.90M
Shares outstanding
185.79M
Price to book
4.60
Return on assets
-1.86%
Return on capital
-2.36%
-5M05M
Net Change in Cash
Net change in cash
(USD)Dec 2024Y/Y change
Net income
-2.52M-89.83%
Cash from operations
4.93M132.46%
Cash from investing
-7.29M-188.68%
Cash from financing
746.00K-36.94%
Net change in cash
-1.85M68.14%
Free cash flow
4.62M129.07%
StockUS listed securityUS headquartered
Previous close
$1.38
Day range
$1.35 - $1.42
Year range
$1.34 - $2.54
Market cap
259.18M USD
Avg Volume
1.51M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry. Wikipedia
Founded
Sep 1991
Website
Employees
622
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Main menu
Google apps